Back to today’s briefing

Story perspectives

Urgent Study Links Common UTI Drug to Cancer Risk

6/1/2025

23 5

Summary

Story summary

A recent study by the National Toxicology Program has raised alarms about phenazopyridine hydrochloride, a drug often prescribed for urinary tract infections. Despite its long history of use, this unapproved medication is now linked to a heightened cancer risk, prompting New Jersey to classify it as a hazardous substance back in 2001.

1 of 1

Story summary

A recent study by the National Toxicology Program has raised alarms about phenazopyridine hydrochloride, a drug often prescribed for urinary tract infections. Despite its long history of use, this unapproved medication is now linked to a heightened cancer risk, prompting New Jersey to classify it as a hazardous substance back in 2001.